PADMANEE SHARMA to Pemetrexed
This is a "connection" page, showing publications PADMANEE SHARMA has written about Pemetrexed.
Connection Strength
0.028
-
Phase II trial of pemetrexed plus gemcitabine in patients with locally advanced and metastatic nonclear cell renal cell carcinoma. Am J Clin Oncol. 2013 Oct; 36(5):450-4.
Score: 0.028